Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Richard G. Moore

ResearcherPublications, citations & collaboration network

Richard G. Moore is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 342 works, 15,247 citations, an h-index of 55 and an i10-index of 138.

342
Works
15,247
Citations
55
h-index
138
i10-index

How has Richard G. Moore's publication output changed over time?

ScholarIQpublication output · 1999–2023

Output grew0% over the shown period — from 1 works in 1999 to 1 in 2023.

1
2
1
2
1
1
1
1
19992002200720082010201120192023

What are the most-cited papers on Richard G. Moore?

ScholarIQmost cited works
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
Antonio González-Martı́n, Bhavana Pothuri, Ignace Vergote, René dePont Christensen, Whitney A. Spannuth Graybill, Mansoor R. Mirza, Colleen McCormick, Domenica Lorusso, Paul Hoskins, Gilles Freyer, Klaus Baumann, К. Jardon, Andrés Redondo, Richard G. Moore, Christof Vulsteke, Roisin E. O’Cearbhaill, Bente Lund, Floor Backes, Pilar Barretina-Ginesta, Ashley Haggerty, María Jesús Rubio-Pérez, Mark S. Shahin, Giorgia Mangili, William H. Bradley, Ilan Bruchim, Kaiming Sun, Izabela A. Malinowska, Yong Li, Divya Gupta, Bradley J. Monk
New England Journal of Medicine. 20192,291 CitationsOPEN ACCESS
Metacognitive awareness and prevention of relapse in depression: Empirical evidence.
John D. Teasdale, Richard G. Moore, Hazel Hayhurst, Marie Pope, Susan P. Williams, Zindel V. Segal
S118719888. 2002966 Citations
Metacognitive awareness and prevention of relapse in depression: Empirical evidence.
John D. Teasdale, Richard G. Moore, Hazel Hayhurst, Marie Pope, Susan P. Williams, Zindel V. Segal
S118719888. 2002900 Citations
A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
Richard G. Moore, D. Scott McMeekin, Amy Brown, Paul DiSilvestro, Michael Craig Miller, W. Jeffrey Allard, W Gajewski, Robert J. Kurman, Robert C. Bast, Steven J. Skates
Gynecologic Oncology. 2008872 Citations
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer
Ramez N. Eskander, Michael W. Sill, Lindsey Beffa, Richard G. Moore, Joanie M. Hope, Fernanda Musa, Robert S. Mannel, Mark S. Shahin, Guilherme Cantuaria, Eugenia Girda, Cara Mathews, Juraj Kavecansky, Charles A. Leath, Lilian T. Gien, Emily Hinchcliff, Shashikant Lele, Lisa M. Landrum, Floor Backes, Roisin E. O’Cearbhaill, Tareq Al Baghdadi, Emily K. Hill, Premal H. Thaker, Veena S. John, Stephen Welch, Amanda N. Fader, Matthew A. Powell, Carol Aghajanian
New England Journal of Medicine. 2023733 CitationsOPEN ACCESS

Related on ScholarIQ

University of Rochester Medicine
Institution
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
Paper
Metacognitive awareness and prevention of relapse in depression: Empirical evidence.
Paper
Metacognitive awareness and prevention of relapse in depression: Empirical evidence.
Paper
A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
Paper
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer
Paper
470M+ articles · free account